Announce Date | 04/23/2025 |
EPS Normalized Actual | $0.0026 (Beat by $0.0426) |
EPS GAAP Actual | $0.0026 (Beat by $0.0426) |
Revenue Actual | $1.28054B |
Revenue Surprise | Beat by $1280.54M |
Announce Date | 07/01/2025 (Pre-Market) |
EPS Normalized Estimate | $0.23397 |
EPS GAAP Estimate | $0.23397 |
Revenue Estimate | $1.595677741B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2027 | 0.58 | 10.19 | 0.55576 | 0.60145 | 2 |
Dec 2026 | 1.15 | 5.14 | 0.92 | 1.38 | 2 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ1 2025 (Mar 2025) | 0.0026 | 0.0026 | 1.28054B | -17.95% | 1280.54M |
FQ4 2024 (Dec 2024) | -0.13 | -0.13 | 1.16214B | -36.33% | 1162.14M |
FQ3 2024 (Sep 2024) | -2.45 | -2.45 | 1.35722B | 25.48% | 1357.22M |
FQ2 2024 (Jun 2024) | 0.0277 | 0.0277 | 1.34819B | 43.71% | 1348.19M |
FQ1 2024 (Mar 2024) | 0.13 | 0.13 | 1.51036B | 47.58% | 1510.36M |
FQ4 2023 (Dec 2023) | 0.15 | 0.15 | 1.58432B | 50.23% | 1584.32M |
FQ3 2023 (Sep 2023) | 0.0002 | 0.0002 | 1.01145B | 28.07% | 1011.45M |
FQ2 2023 (Jun 2023) | 0.41 | 0.41 | 0.758885B | 18.01% | 758.89M |
FQ4 Announce Date
07/01/2025 (Pre-Market)
Consensus EPS Estimates
0.23397
Consensus Revenue Estimates
1.595677741B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 0.14 | -- | 0.12979 | 0.14993 | 5 |
FQ3 2027 (Sep 2027) | 0.17 | -- | 0.1576 | 0.18205 | 2 |
FQ2 2027 (Jun 2027) | 0.15 | -- | 0.13906 | 0.16064 | 2 |
FQ1 2027 (Mar 2027) | 0.12 | -- | 0.11125 | 0.12851 | 2 |
FQ4 2026 (Oct 2026) | 0.36 | -- | 0.33391 | 0.3836 | 5 |
FQ3 2026 (Jul 2026) | 0.34 | -- | 0.31536 | 0.36229 | 5 |
FQ2 2026 (Jun 2026) | 0.35 | -- | 0.34463 | 0.36231 | 5 |
FQ1 2026 (Mar 2026) | 0.33 | 99.21 | 0.32494 | 0.34161 | 11 |
FQ4 2025 (Oct 2025) | 0.2819 | 146.12 | 0.26147 | 0.30038 | 11 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 1.39B | -- | 1.32B | 1.47B | 5 |
FQ3 2027 (Sep 2027) | 1.43B | -- | 1.35B | 1.51B | 4 |
FQ2 2027 (Jun 2027) | 1.4B | -- | 1.32B | 1.48B | 5 |
FQ1 2027 (Mar 2027) | 1.37B | -- | 1.29B | 1.44B | 4 |
FQ4 2026 (Oct 2026) | 1.68B | -- | 1.59B | 1.77B | 8 |
FQ3 2026 (Jul 2026) | 1.67B | -- | 1.58B | 1.76B | 5 |
FQ2 2026 (Jun 2026) | 1.67B | -- | 1.65B | 1.72B | 5 |
FQ1 2026 (Mar 2026) | 1.66B | 22.81 | 1.64B | 1.7B | 5 |
FQ4 2025 (Oct 2025) | 1.64B | 29.08 | 1.55B | 1.72B | 6 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
6
EPS # of Misses
2
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | 0.0026 | 0.0026 | 100% | |
FQ4 2024 (Dec 2024) | -0.13 | -0.13 | 100% | |
FQ3 2024 (Sep 2024) | -2.45 | -2.45 | 100% | |
FQ2 2024 (Jun 2024) | 0.0277 | 0.0277 | 100% | |
FQ1 2024 (Mar 2024) | 0.13 | 0.13 | 100% | |
FQ4 2023 (Dec 2023) | 0.15 | 0.15 | 100% | |
FQ3 2023 (Sep 2023) | 0.0002 | 0.0002 | 100% | |
FQ2 2023 (Jun 2023) | 0.41 | 0.41 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | $0B | $1.28B | $1280.54M | 100% |
FQ4 2024 (Dec 2024) | $0B | $1.16B | $1162.14M | 100% |
FQ3 2024 (Sep 2024) | $0B | $1.36B | $1357.22M | 100% |
FQ2 2024 (Jun 2024) | $0B | $1.35B | $1348.19M | 100% |
FQ1 2024 (Mar 2024) | $0B | $1.51B | $1510.36M | 100% |
FQ4 2023 (Dec 2023) | $0B | $1.58B | $1584.32M | 100% |
FQ3 2023 (Sep 2023) | $0B | $1.01B | $1011.45M | 100% |
FQ2 2023 (Jun 2023) | $0B | $0.76B | $758.89M | 100% |